# A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)

> **NCT02718131** · NA · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 5 (actual)

## Conditions studied

- NF1
- Congenital Pseudarthrosis of Tibia

## Interventions

- **DEVICE:** INFUSE Bone Graft (BMP-2)
- **PROCEDURE:** Control Group

## Key facts

- **NCT ID:** NCT02718131
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Insufficient enrollment to meet the statistical requirements
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718131, "A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02718131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*